title: Treatment modalities in superficial bladder cancer.
authors.affiliation: Veterans Administration Hospital, East Orange, NJ 07018.
authors.forename: R
authors.initials: R
authors.lastname: Irwin
authors.forename: H
authors.initials: H
authors.lastname: Zincke
authors.forename: M J
authors.initials: MJ
authors.lastname: Droller
authors.forename: G R
authors.initials: GR
authors.lastname: Prout
authors.forename: M S
authors.initials: MS
authors.lastname: Soloway
mesh_terms: D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000628:therapy*; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D016685:Mitomycin; D008937:Mitomycins / Q000627:therapeutic use; D010212:Papilloma / Q000628:therapy*; D013852:Thiotepa / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents; D001500:BCG Vaccine; D008937:Mitomycins; D016685:Mitomycin; D004317:Doxorubicin; D013852:Thiotepa